资讯

The New York Times1 个月
Trump’s Astonishing 100 Days, in 8 Charts
The first 100 days of Donald J. Trump’s second presidency have been a study of extremes, especially when compared with the start of presidential terms over the last century. Compared with other ...
psychiatryadvisor.com3 个月
FDA Approves TNKase for Acute Ischemic Stroke
HealthDay News — The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
ophthalmologyadvisor3 个月
FDA Approves TNKase for Acute Ischemic Stroke
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. HealthDay News — The U.S. Food ...
pulmonologyadvisor3 个月
TNKase Approved for Treatment of Acute Ischemic Stroke
TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...
Too Old to Operate3 个月
FDA Approves TNKase for Acute Ischemic Stroke
THURSDAY, March 6, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke ...
The Guam Daily Post3 个月
FDA Approves TNKase for Acute Ischemic Stroke
THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic ...
healthday3 个月
FDA Approves TNKase for Acute Ischemic Stroke
THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic ...